Join us as we go over our top stories from the week:
New Research Suggests Effectiveness of Simple Blood Test for Early Detection of Breast Cancer
Apple-Platform-Based APP Launched to Track Amyotrophic Lateral Sclerosis Progression in Clinical Trials
New UK Site Management Organization Open for Business with New Northern England Investigator Site.
Velocity Clinical Doubles its Size with New Acquisitions including Advanced Clinical Research and Rapid Medical Research and Evidences Commitment to Vision.
Cancer Study Terminated at Rensselaer Polytechnic Institute’s Biomedical Research Labs due to Quality Issues.
Real-World Data Shows Results of Ranibizumab in the OCEAN Study for Treatment of Retinal Vein Occlusion.
KOL Hepatologist to Discuss Clinical Trial Results for Patients with Alcoholic Hepatitis.
VBL Therapeutics Announces New IND for an Investigator-Sponsored Phase 2 Trial of VB-111 in Recurrent Glioblastoma.
Novo Nordisk Enters Race to Develop NASH Treatment.
Gold Coast Investigators Quest for Malaria Vaccine.
PERL Study Results Show Uric Acid Has No Impact on Diabetic Kidney Disease.
Colombian Woman’s Genes Offer New Clues to Staving Off Alzheimer’s.
Are Young-Blood Transfusions Helping Seniors Age Less?
Vanderbilt University Recruits Glaucoma Patients for Allergan Medication Using Novel ‘Dropless’ Method.
Clinical Trials 05.50
Liver Disease 04.11